China International Capital Corp (CICC) and Fosun International Capital, a subsidiary of Fosun International, are joint financial advisers for the deal. “The listing status of the company no longer provides …
One of China’s biggest pharmaceutical producers will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, …
Fosun International, through its Shanghai-based healthcare unit, is ready to deliver its first locally built Da Vinci surgical robots to its clients in a major step to make advanced medical …